What is the true risk of a pharmacokinetic drug–drug interaction? Uwe Fuhr Editorial 08 August 2007 Pages: 897 - 899
Maintenance of indinavir by dose adjustment in HIV-1-infected patients with indinavir-related toxicity J.-C. WasmuthI. LambertzJ. K. Rockstroh Clinical Trial 10 August 2007 Pages: 901 - 908
An analysis of the clinical development of drugs in Norway for the years 2000 and 2004: the influence of the pharmaceutical industry Finn O. WintherOla P. HoleSigurd Nitter-Hauge Debate Article 03 August 2007 Pages: 909 - 912
Interaction between a commercially available St. John’s wort product (Movina) and atorvastatin in patients with hypercholesterolemia L. AndrénÅ AndreassonR. Eggertsen Pharmacodynamics 15 August 2007 Pages: 913 - 916
Possible role of MDR1 two-locus genotypes for young-age onset ulcerative colitis but not Crohn’s disease T. FiedlerC. BüningA. Johne Pharmacogenetics 31 July 2007 Pages: 917 - 925
Dose-escalation study of isoniazid in healthy volunteers with the rapid acetylator genotype of arylamine N-acetyltransferase 2 Ryuji KubotaMasako OhnoJunichi Azuma Pharmacogenetics 31 July 2007 Pages: 927 - 933
Tenofovir comedication does not impair the steady-state pharmacokinetics of ritonavir-boosted atazanavir in HIV-1-infected adults Nils von HentigBrenda DauerSebastian Harder Pharmacokinetics and Disposition 31 July 2007 Pages: 935 - 940
Voriconazole and fluconazole increase the exposure to oral diazepam Teijo I. SaariKari LaineKlaus T. Olkkola Pharmacokinetics and Disposition 04 August 2007 Pages: 941 - 949
Gender-associated differences in pharmacokinetics and anti-arrhythmic effects of flecainide in Japanese patients with supraventricular tachyarrhythmia Kosuke DokiMasato HommaYukinao Kohda Pharmacokinetics and Disposition 31 July 2007 Pages: 951 - 957
Digoxin and mortality in atrial fibrillation: a prospective cohort study Pär HallbergJohan Lindbäckfor the RIKS-HIA group Pharmacoepidemiology and Prescription 08 August 2007 Pages: 959 - 971
Adverse events of blood-pressure-lowering drugs: evidence of high incidence in a clinical setting Carla B.C. GonçalvesLeila B. MoreiraFlávio D. Fuchs Pharmacoepidemiology and Prescription 11 August 2007 Pages: 973 - 978
Patient-reporting of side effects may provide an important source of information in clinical practice Juliet M. FosterThys van der MolenLolkje de Jong - van den Berg Letter to the Editors Open access 06 July 2007 Pages: 979 - 980
Reply to letter by Foster, van der Molen and de Jong-van den Berg Pasi LampelaSirpa HartikainenRisto Huupponen Letter to the Editors 04 August 2007 Pages: 981 - 981